NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









FA Bio

FA Bio

Private
HarpendenHealthcare & Life Scienceshttps://fa-bio.net/

Last Round

Grant

Mar 12, 2024

Total Funding Raised

$2.95M

Company Overview

FA Bio is an agricultural biotechnology company that discovers and develops microbial bioproducts, including biocontrols, biostimulants, and biofertilisers, to replace chemical inputs and improve soil health.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Environmental Monitoring, Sustainable Materials

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

microbial bioproductsbiopesticidesbiostimulantsbiofertilizersagtechmicrobial discoveryregenerative agriculturebiological crop protectionsoil healthbiologicalsmicrobiome researchsustainable agriculturebio-inputsagricultural biotechnologysynthetic biology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

FA Bio Comps

Public and private peers based on sector, stage, and business model.

FA Bio comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

FA Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantMar 12, 2024
VC RoundJan 9, 2024
GrantFeb 6, 2023
SeedSep 1, 2021
Pre SeedApr 21, 2016

Key People

Founding team and executive leadership

Angela de Manzanos

CEO

Executive Team

Mark Hollingworth

Chief Financial Officer

Executive Team

FA Bio Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 22, 2026

    Monthly visitors grew 232% MoM, reaching 2.6K.

  • Jun 1, 2025

    Monthly visitors increased 47% MoM, reaching 2.8K.

FA Bio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

FA Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about FA Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersHarpenden
Employee Range28
Year Founded2015
Last FundingMar 12, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.